CHS Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.46B | $39.26B | $45.59B | $47.79B | $38.45B | $28.41B | $31.90B | $32.68B |
| Cost of Revenue | $34.33B | $37.51B | $43.21B | $45.66B | $37.50B | $27.42B | $30.52B | $31.59B |
| Gross Profit | $1.14B | $1.75B | $2.38B | $2.13B | $951.4M | $981.8M | $1.38B | $1.09B |
| Gross Margin | 3.2% | 4.5% | 5.2% | 4.5% | 2.5% | 3.5% | 4.3% | 3.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.05B | $1.17B | $1.03B | $997.8M | $745.6M | $704.5M | $724.7M | $639.8M |
| Operating Income | $90.8M | $584.4M | $1.34B | $1.13B | $205.8M | $277.3M | $659.6M | $452.4M |
| Operating Margin | 0.3% | 1.5% | 2.9% | 2.4% | 0.5% | 1.0% | 2.1% | 1.4% |
| Interest Expense | $146.1M | $104.1M | $137.4M | $114.2M | $104.6M | $117.0M | $167.1M | $149.2M |
| Pretax Income | $614.8M | $1.10B | $2.01B | $1.81B | $515.3M | $386.9M | $815.6M | $671.2M |
| Income Tax Expense | $16.8M | $-4.9M | $107.7M | $132.1M | $-38.2M | $-36.7M | $-12.5M | $-104.1M |
| Net Income | $597.9M | $1.10B | $1.90B | $1.68B | $554.0M | $422.4M | $829.9M | $775.9M |
| Net Margin | 1.7% | 2.8% | 4.2% | 3.5% | 1.4% | 1.5% | 2.6% | 2.4% |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Per Share | — | — | — | — | — | — | — | — |